Products

Still

A calmer break reminder for your Mac.

still.good-guys-labs.com App StoreProductivity & Collaboration / Habits, Focus & Time Tracking

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$4.99/mo
Lower than 61% of peersNiche median $6/mo
Creators
Alex Thevenet
No social account linked
Launched
34d ago
2026-10-17 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Eye, movement, and breathing breaks for Mac

    Oct 17 · 34d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-07-02

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Still
$4.99/once
Apple silicon · macOS 14+

Trial: None · 1 paid tier ($4.99) · Observed 2026-11-06 · Source page

Entry price $4.99/mo, Lower than 61% of peers; “Habits, Focus & Time Tracking” median is $6/mo.View pricing benchmark

Website snapshots

Indexed 2026-10-17

Key pages

Desktop & mobile archive
Home
still.good-guys-labs.com/ Snapshot 2026-11-06

Questions & evidence

How much does Still cost?
Still: $4.99/once. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Still get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Still and what platforms does it support?
Still is catalogued under Habits, Focus & Time Tracking: A calmer break reminder for your Mac. Supported platforms: Mobile App.

Related products in this category

Productivity & Collaboration / Habits, Focus & Time Tracking

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.